SCHEMBL7035752

SCHEMBL7035752

Cc1ccccc1NC(=O)c1ccc(C/C=C/c2ccc(Cl)c(Cl)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.52
MAPT P10636 3/20 0.48
POLB P06746 2/20 0.48
HPGD P15428 1/20 0.48
SSTR3 P32745 1/20 0.47
TAS1R3 Q7RTX0 1/20 0.47
TAS1R1 Q7RTX1 1/20 0.47
TAS1R2 Q8TE23 1/20 0.47
S1PR4 O95977 1/20 0.47
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
L3MBTL1 Q9Y468 3/20 0.45
HTT P42858 1/20 0.45
TP53 P04637 1/20 0.44
THRB P10828 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GLA P06280 1/20 0.43
ATM Q13315 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7035753 1.00 LMNA (0.52) LMNAMAPTPOLBHPGDSSTR3
SCHEMBL7036099 0.81 LMNA (0.53) LMNAMAPTPOLBHPGDSSTR3
SCHEMBL7031426 0.81 LMNA (0.53) LMNAMAPTPOLBHPGDSSTR3
SCHEMBL7036097 0.81 LMNA (0.53) LMNAMAPTPOLBHPGDSSTR3
SCHEMBL7031428 0.81 LMNA (0.53) LMNAMAPTPOLBHPGDSSTR3
SCHEMBL7038815 0.81 LMNA (0.50) LMNAMAPTPOLBHPGDSSTR3
SCHEMBL7038814 0.81 LMNA (0.50) LMNAMAPTPOLBHPGDSSTR3
SCHEMBL7029511 0.80 LMNA (0.51) LMNAMAPTPOLBHPGDSSTR3
SCHEMBL7029506 0.80 LMNA (0.51) LMNAMAPTPOLBHPGDSSTR3
SCHEMBL7030757 0.79 LMNA (0.55) LMNAPOLBHPGDTAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030225302-A1 Aromatic amides, their preparation process and their use as pesticides HOECHST SCHERING AGREVO S.A. (FR) 2003-12-04 US claimed
US-20020068838-A1 AROMATIC AMIDES, THEIR PREPARATION PROCESS AND THEIR USE AS PESTICIDES HOECHST SCHERING AGREVO S.A. (FR) 2002-06-06 US claimed
EP-1003714-A1 AROMATIC AMIDES, THEIR PREPARATION PROCESS AND THEIR USE AS PESTICIDES Hoechst Schering AgrEvo S.A. (FR) 2000-05-31 EP claimed
WO-1999001422-A1 AROMATIC AMIDES, THEIR PREPARATION PROCESS AND THEIR USE AS PESTICIDES HOECHST SCHERING AGREVO S.A. (FR) 1999-01-14 WO claimed
US-20030225302-A1 Aromatic amides, their preparation process and their use as pesticides HOECHST SCHERING AGREVO S.A. (FR) 2003-12-04 US disclosed
US-20020068838-A1 AROMATIC AMIDES, THEIR PREPARATION PROCESS AND THEIR USE AS PESTICIDES HOECHST SCHERING AGREVO S.A. (FR) 2002-06-06 US disclosed
EP-1003714-A1 AROMATIC AMIDES, THEIR PREPARATION PROCESS AND THEIR USE AS PESTICIDES Hoechst Schering AgrEvo S.A. (FR) 2000-05-31 EP disclosed
WO-1999001422-A1 AROMATIC AMIDES, THEIR PREPARATION PROCESS AND THEIR USE AS PESTICIDES HOECHST SCHERING AGREVO S.A. (FR) 1999-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020068838-A1 AROMATIC AMIDES, THEIR PREPARATION PROCESS AND THEIR USE AS PESTICIDES CBR1, CBR3, CYP2E1 LMNA 1663/4885MAPT 4759/4885POLB 3707/4885
US-20030225302-A1 Aromatic amides, their preparation process and their use as pesticides CBR3, CBR1, CYP2E1 LMNA 1581/4885MAPT 4727/4885POLB 3491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.